SMi Systems

SMi starts the new year with a US patent allowance! The same patent has already been granted in the UK and Hong Kong and further patent grants are anticipated in 2025. See the press release on our website - https://lnkd.in/en2323kR #multiomics #singlemolecule #drugdiscovery #diagnostics #lifesciences #techbio

We are delighted to introduce Dr Ankur Mutreja, a Senior Advisor to SMi. Ankur is a Director of Strategy at PATH, a specialist in implementing strategic health programs, and is part of a growing team of advisors helping to guide the applications of SMi’s technology. Ankur’s experience contributes greatly to SMi’s thinking on vaccine development and routine population testing, both of which will be addressed by SMi’s early commercial products. If you want to know more - https://lnkd.in/en2323kR #multiomics #singlemolecule #drugdiscovery #diagnostics #lifesciences #techbio #startup #strategy

We are delighted to introduce Dr Ankur Mutreja, a Senior Advisor to SMi. Ankur is a Director of Strategy at PATH, a specialist in implementing strategic health programs, and is part of a growing team of advisors helping to guide the applications of SMi’s technology. Ankur’s experience contributes greatly to SMi’s thinking on vaccine development and routine population testing, both of which will be addressed by SMi’s early commercial products. If you want to know more - https://lnkd.in/en2323kR #multiomics #singlemolecule #drugdiscovery #diagnostics #lifesciences #techbio #startup #strategy

SMi is delighted to be recognised by Albert Vilella as being among the leading biosensor companies. His blog post below highlights that SMi’s technology can detect a wide range of biomolecules including proteins, nucleic acids and small molecules, making it highly valuable in both drug discovery and diagnostics. #biosensors #multiomics #singlemolecule #drugdiscovery #diagnostics #lifesciences #techbio

We are excited to release the fifth of our ‘SMi Shorts’ (https://lnkd.in/en2323kR) – a set of opinion pieces that introduce the use of single molecule imaging for drug discovery and disease diagnosis. This fifth 'Short' summarises how SMi has aligned risk processes for the development of both its RUO and IVD platforms. #multiomics #singlemolecule #drugdiscovery #diagnostics #lifesciences #techbio

We are delighted to have featured as a case study by Batalas, a specialist consultancy whose auditor training helped SMi to implement a more effective Quality Management System. #smisystems #iso13485

Our CEO Andrew Thompson and CFO James Clark are attending #siftedsummit on Thursday 3rd October, and talking about how SMi’s single-molecule data will transform life sciences research and enable AI-driven drug discovery. Looking forward to seeing you there 👉 Sifted Summit #siftedsummit #SeriesA #techbio #singlemolecule #smisystems

It’s been extremely valuable to work with Arpita Desai, Jan-Bart Hak and Louis Habets from ProPharma Group in developing our ISO 13485 Quality Management System and the story of how we achieved this is featured on their website. #wearepropharma #smisystems #iso13485

Meet the newest recruit to our growing Assay Development team, Helen Dakin.    A recent PhD graduate from the University of Cambridge, Helen brings a wealth of knowledge to SMi, including therapeutic antibody discovery, single molecule imaging, and the use of high throughput technologies. Welcome to SMi Helen! #assaydevelopment #multiomics #singlemolecule #drugdiscovery #diagnostics #lifesciences #techbio

We are excited to release the fourth of our ‘SMi Shorts’ (https://lnkd.in/en2323kR) – a set of opinion pieces that introduce the use of single molecule imaging for drug discovery and disease diagnosis. This fourth 'Short' summarises the importance of advanced algorithms to detect and analyse single molecules. #multiomics #singlemolecule #drugdiscovery #diagnostics #lifesciences #techbio